Skip to main content
RPRX filings

Corporate insider profile

Christopher Hite Filing Activity

Latest reported as EVP & Chairman, Partnering of Royalty Pharma plc (RPRX).

Purchase filings
0
Reported companies
1
Net open-market value
-$8,159,280.00
Latest transaction
Jun 23, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 23, 2026Royalty Pharma plc (RPRX)EVP & Chairman, PartneringSale150,000$54.40$8,159,280